<DOC>
	<DOCNO>NCT00760695</DOCNO>
	<brief_summary>A pilot study design reveal effect Marinol / dronabinol , CB 1 agonist . Primary end point : To estimate weight gain EDI score patient receive Marinol compare placebo Secondary end point : Motor inner restlessness hormonal change treatment .</brief_summary>
	<brief_title>Cannabinoid Receptor ( CB1 ) Agonist Treatment Severe Chronic Anorexia Nervosa</brief_title>
	<detailed_description>The goal study reveal pilot trial treatment patient severe chronic AN Marinol® ( dronabinol , CB1 agonist ) significant effect : - Weight - Eating Disorder Inventory ( EDI ) scale - Motor inner restlessness ( estimate accelerometry ) - Endocrine parameter ( see , paragraph 4.4 ) This study randomize , double blind , placebo control cross study . 24 patient chronic AN meeting inclusion criterion randomize either receive Marinol® placebo . After four week two group undergo wash-out period receive opposite therapeutic regime another four week .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Patients treatment AN . Patients attend ambulatory treatment , expect admitted hospital ANrelated pathology discharge study period . Patients admit Department Endocrinology M Psychiatric Department P expect discharged study period . Age 18 . Duration disease 5 year . Patients compulsory treatment suffer mania , schizophrenia primary depression . Patients medical psychiatric event relate related underlie eat disorder require prolonged admission hospital study . Patients unstable heart disease ( relevant change medication prior study ) limitation activity ( comfortable moderate exertion / rest ) . Patients attend weekly control . If severe adverse event ( SAE ) / drug reaction ( SADR ) suspect . Patients actually history alcohol , cannabis , opioids central stimulate drug abuse . Patients know allergy dronabinol sesame oil . Fertile , menstruate woman use safe contraception . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>anorexia nervosa</keyword>
	<keyword>chronic</keyword>
	<keyword>dronabinol</keyword>
	<keyword>weight gain</keyword>
	<keyword>EDI</keyword>
</DOC>